Structural characterization of human de novo protein NCYM and its complex with a newly identified DNA aptamer using atomic force microscopy and small-angle X-ray scattering
NCYM, a Homininae-specific oncoprotein, is the first de novo gene product experimentally shown to have oncogenic functions. NCYM stabilizes MYCN and β-catenin via direct binding and inhibition of GSK3β and promotes cancer progression in various tumors. Thus, the identification of compounds that bind...
Main Authors: | Seigi Yamamoto, Fumiaki Kono, Kazuma Nakatani, Miwako Hirose, Katsunori Horii, Yoshitaka Hippo, Taro Tamada, Yusuke Suenaga, Tatsuhito Matsuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1213678/full |
Similar Items
-
Inhibition of OCT4 binding at the MYCN locus induces neuroblastoma cell death accompanied by downregulation of transcripts with high-open reading frame dominance
by: Kazuma Nakatani, et al.
Published: (2024-02-01) -
Selection of Aptamers for Use as Molecular Probes in AFM Detection of Proteins
by: Maria O. Ershova, et al.
Published: (2023-12-01) -
Current Status of Patient-Derived Ovarian Cancer Models
by: Yoshiaki Maru, et al.
Published: (2019-05-01) -
Editorial: Development of in vitro toxicology methods using organoid systems and toxicogenomic approaches
by: Toshio Imai, et al.
Published: (2022-10-01) -
Unraveling the morphological diversity of P(VDF-ter-TrFE-ter-CTFE) semi-crystalline terpolymers via combined AFM and SAXS experiments
by: Sara Zanchi, et al.
Published: (2023-03-01)